Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

202.54 +3.57 (+1.79%)
Streaming Delayed Price Updated: 11:39 AM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,823
Open 202.00
Bid (Size) 202.47 (4)
Ask (Size) 202.67 (2)
Prev. Close 198.97
Today's Range 199.62 - 202.67
52wk Range 165.75 - 249.11
Shares Outstanding 185,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Veeva Systems a Buy Now?
The stock is trading at a high multiple despite revenue that's growing by mid-single-digit percentages. 
Via The Motley Fool
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
 
Via Benzinga

Performance

YTD
-0.65%
-0.65%
1 Month
+9.13%
+9.13%
3 Month
-6.16%
-6.16%
6 Month
-8.17%
-8.17%
1 Year
-3.60%
-3.60%

More News

Read More
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
From IQVIA
Via Business Wire
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA Hldgs's Return On Capital Employed Overview
Via Benzinga
Expert Ratings for IQVIA Hldgs
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
Via Benzinga
This Foreboding Sign Looms Over IQVIA Hldgs's Chart
Via Benzinga
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
From IQVIA
Via Business Wire
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
From IQVIA
Via Business Wire
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
From IQVIA
Via Business Wire
Death Cross Looms Over IQVIA Hldgs Investors
Via Benzinga
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
From IQVIA Holdings Inc.
Via Business Wire
The Latest Analyst Ratings for IQVIA Hldgs
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Via Benzinga
Here's How Much You Would Have Made Owning IQVIA Hldgs Stock In The Last 5 Years
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.